Literature DB >> 1554712

Mutations affecting the activity of the Shiga-like toxin I A-chain.

R L Deresiewicz1, S B Calderwood, J D Robertus, R J Collier.   

Abstract

Like ricin, Escherichia coli Shiga-like toxin I (SLT-I) inactivates eukaryotic ribosomes by catalytically depurinating adenosine 4324 in 28S rRNA. Although the primary structure of the enzymatic portion of the molecule (Slt-IA) is known to contain regions of significant homology to the ricin A chain (RTA), and although certain residues have been implicated in catalysis, the crystal structure of Slt-IA has not been solved nor has the geometry of its active site been well defined. In order to derive a more complete understanding of the nature of the Slt-IA active site, we placed the slt-IA gene under control of an inducible promoter in Saccharomyces cerevisiae. Induction of the cloned element was lethal to the host. This lethality was the basis for selection of an attenuated mutant of Slt-IA changed at tyrosine 77, a locus not previously linked to the active site. As well, it permitted evaluation of the toxicity of a number of mutant Slt-IA cassettes that we constructed in vitro. Putative active-site residues implicated in this fashion and in other studies were mapped to an energy-minimized computer model of Slt-IA that had been generated on the basis of the known crystal structure of RTA. A cleft was identified on one face of the protein in which all implicated residues clustered, irrespective of their distances from one another in the primary structure of the molecule. Many of the chemical features anticipated in the active site of an RNA N-glycosidase are indeed present on the amino acid side chains occupying the cleft.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1554712     DOI: 10.1021/bi00127a032

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  16 in total

1.  Identification and characterization of a new variant of Shiga toxin 1 in Escherichia coli ONT:H19 of bovine origin.

Authors:  Christine Bürk; Richard Dietrich; Gabriele Açar; Maximilian Moravek; Michael Bülte; Erwin Märtlbauer
Journal:  J Clin Microbiol       Date:  2003-05       Impact factor: 5.948

2.  Identification of amino acids critical for the cytotoxicity of Shiga toxin 1 and 2 in Saccharomyces cerevisiae.

Authors:  Rong Di; Eric Kyu; Varsha Shete; Hemalatha Saidasan; Peter C Kahn; Nilgun E Tumer
Journal:  Toxicon       Date:  2010-12-22       Impact factor: 3.033

3.  Monoclonal antibody 11E10, which neutralizes shiga toxin type 2 (Stx2), recognizes three regions on the Stx2 A subunit, blocks the enzymatic action of the toxin in vitro, and alters the overall cellular distribution of the toxin.

Authors:  Michael J Smith; Angela R Melton-Celsa; James F Sinclair; Humberto M Carvalho; Cory M Robinson; Alison D O'Brien
Journal:  Infect Immun       Date:  2009-05-11       Impact factor: 3.441

4.  Investigation of ribosome binding by the Shiga toxin A1 subunit, using competition and site-directed mutagenesis.

Authors:  L M Skinner; M P Jackson
Journal:  J Bacteriol       Date:  1997-02       Impact factor: 3.490

5.  Isolation and identification of an Enterobacter cloacae strain producing a novel subtype of Shiga toxin type 1.

Authors:  William S Probert; Cassandra McQuaid; Kimmi Schrader
Journal:  J Clin Microbiol       Date:  2014-04-23       Impact factor: 5.948

6.  Conserved Arginines at the P-Protein Stalk Binding Site and the Active Site Are Critical for Ribosome Interactions of Shiga Toxins but Do Not Contribute to Differences in the Affinity of the A1 Subunits for the Ribosome.

Authors:  Debaleena Basu; Jennifer N Kahn; Xiao-Ping Li; Nilgun E Tumer
Journal:  Infect Immun       Date:  2016-11-18       Impact factor: 3.441

Review 7.  Shiga Toxin (Stx) Classification, Structure, and Function.

Authors:  Angela R Melton-Celsa
Journal:  Microbiol Spectr       Date:  2014-08

8.  Intracellular expression of toxic shock syndrome toxin 1 in Saccharomyces cerevisiae.

Authors:  R L Deresiewicz; J A Flaxenburg; M Chan; R W Finberg; D L Kasper
Journal:  Infect Immun       Date:  1994-06       Impact factor: 3.441

9.  An evolved ribosome-inactivating protein targets and kills human melanoma cells in vitro and in vivo.

Authors:  Melissa C Cheung; Leigh Revers; Subodini Perampalam; Xin Wei; Reza Kiarash; David E Green; Aws Abdul-Wahid; Jean Gariépy
Journal:  Mol Cancer       Date:  2010-02-03       Impact factor: 27.401

10.  Minimum domain of the Shiga toxin A subunit required for enzymatic activity.

Authors:  J E Haddad; A Y al-Jaufy; M P Jackson
Journal:  J Bacteriol       Date:  1993-08       Impact factor: 3.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.